Achieving better results for peritoneal dialysis in recent years;Logrando mejores resultados para la diálisis peritoneal en los últimos años

Nefrologia

Volumn 32, Issue 5, 2012, Pages 587-596

  Quirós Ganga, Pedro L ^a   Remón Rodríguez, César ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

Biocompatible dialysis fluids; Outcome; Peritoneal dialysis; Survival

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PERITONEAL DIALYSIS; STANDARD; SURVIVAL RATE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84868227091     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Jun.11456     Document Type: Article

References (24)

1. Xue JL, Everson SE, Constantini EG, Ebben JP, Chen SC, Agodoa LY, et al. Peritoneal and hemodialysis II: Mortality risk associated with initial patient characteristics. Kidney Int 2002;61:741-6.
2. Remón-Rodríguez C, Quirós Ganga PL. La evidencia actual demuestra una equivalencia de resultados entre las técnicas de diálisis. Nefrologia 2011;31(5):520-7.
3. Van Manen JF, Van Dijk PC, Stel V, Dekker FW, Clèries M, Conte F, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007;22:187-95.
4. Locatelli F, Marcelli D, Conte F. Dialysis patient outcomes in Europe vs the USA. Nephrol Dial Transplant 1997;12:1816-9.
5. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int Suppl 2006;(103):S3-11.
6. Portolés J, Remón C. En busca de la eficiencia y la sostenibilidad del tratamiento sustitutivo renal integrado. Nefrologia 2010;1 (Suppl Extr 1):2-7.
7. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K, et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007;18:2781-8.
8. Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009;24:3557-66.
9. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-63.
10. Registro Español de Enfermos Renales. Informe de Diálisis y Trasplante 2010. Available at: http://www.senefro.org/modules.php?name=webstructure&idwebstructure=128
11. Rodríguez CR, Quirós PL, Cunquero JM, Ruiz SR, Fosalba NA, Fernández AR, et al. Diez años de diálisis peritoneal en Andalucía (1999-2008): datos epidemiológicos, tipos de tratamiento, peritonitis, comorbilidad y supervivencia de pacientes y técnica. Nefrologia 2010;30(1):46-53.
12. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011;171:110-8.
13. Rufino JM, García C, Vega N, Macía M, Hernández D, Rodríguez A, et al. Diálisis peritoneal actual comparada con hemodiálisis: análisis de supervivencia a medio plazo en pacientes incidentes en diálisis en la Comunidad Canaria en los últimos años. Nefrologia 2011;31(2):174-84.
14. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010;21:499-506.
15. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002;17:112-7.
16. McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int 2007;71(6):486-90.
17. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005;25(3):248-55.
18. Grzegorzewska AE. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome? Pol Arch Med Wewn 2009;119(4):242-7.
19. Takatori Y, Akagi S, Sugiyama H, Inoue J, Kojo S, Morinaga H, et al. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial. Clin J Am Soc Nephrol 2011;6:1337-44.
20. Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patientsrelated and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant 2002;17:1655-60.
21. Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan. Perit Dial Int 2006;26(2):136-43.
22. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int 2008;28(2):174-82.
23. Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F, Sánchez Tomero JA, et al. La diálisis peritoneal es la mejor alternativa costo-efectiva para la sostenibilidad del tratamiento con diálisis. Nefrologia 2011;31(5):505-13.
24. La diálisis peritoneal en la planificación integral del tratamiento sustitutivo renal. Available at: www.alcer.org/mm/file/dp.pdf